Production, Screening and Characterization of a Monoclonal Antibody to
Murine Interferon-/~ (Accepted 5 October 1982) SUMMARY A hybrid murine myeloma (2-13F5) secreting a monoclonal antibody that specifically bound and neutralized murine interferon fl has been isolated. Affinity chromatography with immobilized 2-13F5 monoclonal antibody of murine IFN (containing both IFN-~ and IFN-fl) separated an IFN-fl preparation that demonstrated one band with Coomassie Brilliant Blue staining of SDS-PAGE at a molecular weight of 35000 and a specific activity of 4.3 x l0 s units/mg of protein. This monoclonal antibody neither bound nor neutralized murine IFN-~. In addition, it bound only 87~ of the interferon demonstrating a molecular weight of 35K. Possible explanations of this partial binding are discussed.
Two classes of murine interferon (MuIFN), IFN-~ and IFN-fl, may be distinguished serologically and by molecular weight (Yamamoto & Kawade, 1980) . Unlike the human system, in which IFN-~ can be induced independently of IFN-fl, induction of murine fibroblasts or leukocytes with virus or standard inducing agents [e.g. poly(rI)-poly(rC)] results in production of both IFN-~ and IFN-fl. Currently, the best method for separating the murine interferons effectively is sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) (Yamamoto & Kawade, 1976) ; this method is generally performed on a small scale, and, therefore, results in only small amounts of interferon.
Recently, hybridomas secreting monoclonal antibodies specific for various human and murine interferons have been isolated. These antibodies have been useful for both characterization and purification of interferons. Monoclonal antibodies to human IFN-c~ and IFN-fl have demonstrated no cross-reactivity between the two interferons and have been utilized in affinity chromatography for the purification of human interferons (Secher & Burke, 1980; Hochkeppel et al., 1981; Staehelin et al., 1981) . The situation is not as distinct in the murine system. Although Bosveld et al. (1982) reported the isolation of a monoclonal antibody that reacted with IFN-fl, but not IFN-~, Mannel et al. (1982) described a monoclonal antibody that reacted with all molecular weight species of murine interferon. Bosveld et al. (1982) did demonstrate that their monoclonal antibody could be used for purification of murine IFN-fl.
It is interesting that not all anti-interferon monoclonal antibodies can neutralize antiviral activity. Hybridomas that were selected by neutralization can, of course, neutralize interferon activity (Secher & Burke, 1980; Bosveld et al., 1982) . These antibodies, however, do not demonstrate a high titre of neutralization. If a binding assay was used as the initial screen, the resulting monoclonal antibody may (Mannel et al., 1982) or may not (Staehelin et al., 1981) neutralize interferon activity. When the antibody demonstrated both binding and neutralizing activities, the binding titre was significantly higher.
In this paper, we report the isolation and characterization of a monoclonal antibody to murine interferon. A binding assay was used to screen the hybridomas since this assay is more rapid than and is at least as sensitive as neutralization. Like Bosveld et al. (1982) , we found that this antibody did not react with murine IFN-cc. In contrast to their work, however, our monoclonal antibody bound only a portion of the murine IFN-fl.
The interferon used for both immunization of rats and screening of hybrid supernatants was prepared by induction of L929 ceils with Newcastle disease virus as previously described (Ogburn et al., 1973) . Purification was performed by immune affinity chromatography with immobilized sheep anti-L929 cell interferon that was exhaustively adsorbed with various suspected contaminants. The specific activity of the pooled eluate of this final chromatographic 0022-1317/83/0000-5297 $02.00 © 1983 SGM step was 1 x 107 to 5 x 107 units/mg of protein. Interferon titres were determined by measuring the protection from the cytopathic effect (c.p.e.) of encephalomyocarditis (EMC) virus on L929 monolayer cells (Havell & Vilcek, 1972; Armstrong, 1971) and were corrected against murine interferon reference standard G002-904-511 distributed by the Reagents Board of the National Institute of Allergy and Infectious Diseases (Bethesda, Md., U.S.A.). Neutralization of antiviral activity was assayed by preincubation of 8 laboratory units of L929 cell interferon with serially diluted supernatants of hybrid cells for 1 h followed by addition of L929 cells, and 24 h later, of EMC virus. Neutralization was defined as the reciprocal of the dilution of supernatant required to inhibit the protective effect of interferon and, therefore, to allow c.p.e, in 50 % of the cells. The neutralization titre was then corrected to account for the difference between the laboratory units and the international reference units; i.e. since 8 laboratory units usually corresponded to 4.8 international reference units, the neutralization titre was multiplied by 0.6.
Female ACI rats (M.A. Bioproducts, Rockville, Md., U.S.A.) received 106 units of MulFN subcutaneously at weekly intervals for 6 weeks. The rats were bled 1 week after the sixth inoculation in order to assay anti-MulFN specific antibody. Although the sera of all rats demonstrated neutralization of antiviral activity, one rat with a neutralization titre of 7680 was chosen for further study. This rat was boosted with 106 units of MulFN intraperitoneally 2 weeks after bleeding. Three days later, the rat was sacrificed and the spleen cells were fused with murine myeloma ceils P3/X63/Ag8 according to the procedure of Kohler & Milstein (1975) , as modified by Kennet et al. (1980) . After fusion, the cells were cultured in Costar microtitre plates. Of the 209 wells seeded, 29 showed positive growth. Supernatants of growing hybrids were screened for anti-interferon activity using an ELISA. The assay was a modification of the procedure described by Voller et al. (1979) . Briefly, 0.3 ml of hybrid supernatant was added to microcuvettes (Gilford) containing 104 units of MulFN and incubated for 2 h at room temperature. After washing, goat anti-rat immunoglobulin (Cappel Laboratories) was added. After 1 h incubation, the cuvettes were washed and alkaline phosphatase-conjugated rabbit anti-goat IgG (Miles Laboratories) was added. After 1 h incubation, the cuvettes were washed and p-nitrophenyl phosphate (1 mg/ml) in diethanolamine buffer was added to obtain the colour reaction. The reaction was terminated after 30 min at 37 °C with 0.05 ml of 6 M_-NaOH and absorption was read at 405 nm. Of the 29 growing hybrids, only four demonstrated positive reactivity in the ELISA. Three of these four hybrids were successfully cloned by limiting dilution; one clone which showed the highest reactivity was recloned and the secondary clone (2-13F5) was further characterized. Supernatants of this hybridoma had titres of 1 : 10000 in the ELISA. This hybridoma was shown to produce an IgG that was precipitable with either staphylococcal Protein A (Cullen & Schwartz, 1976) or with anti-rat IgG. Two-dimensional electrophoresis of these immunoprecipitates revealed one light chain and one heavy chain, thus indicating the monoclonal nature of the 2-13F5 antibody. The secretion of antibodies was checked regularly and the cell line was found to be stable for more than 70 passages.
Since the interferon used as the antigen in the ELISA was only 5 to 10% pure as determined by SDS-PAGE, it was possible that reactivity in the ELISA reflected an antibody specific for the contaminant material. In order to determine whether the monoclonal antibody was specific for interferon, neutralization of antiviral activity was determined. The monoclonal antibody failed to neutralize the antiviral activity of murine L929 cell interferon (containing both IFN-ct and IFN-fl), and did not neutralize the non-glycosylated IFN-ct produced by L929 cells in the presence of tunicamycin (Fujisawa et al., 1978) . These data suggested that the monoclonal antibody was either (i) reacting with contaminant material, or (ii) unable to neutralize, although it could bind, interferon, or (iii) reacting only with IFN-fl.
In order to distinguish between these alternatives, affinity chromatography of partially purified murine L929 cell interferon (specific activity: 5 x 107 units/mg of protein) on immobilized 2-13F5 globulin coupled to Sepharose 4B was performed. The elution profile of protein (A28o) and interferon activity is shown in Fig. 1 (a) . The wash fractions (fractions 1 to 19) contained virtually all the protein and 12% of the total interferon units applied, while the eluate contained 76% of the total biological activity and a specific activity of 4.3 x 108 units/mg of protein. Laemmli (1970) was used, with a 5~ stacking gel and 12.5~ running gel. 1, Mouse L929 cell interferon, polyclonal antibody affinity column-purified; 2, material eluted in the wash from the 2-13F5 antibody column; 3, material specifically bound to the 2-13F5 column, interferon specific activity 4.3 x 108 units/mg of protein. Phosphorylase B (92-5K), bovine serum albumin (66.2K), ovalbumin (45-0K), carbonic anhydrase (31-OK), soybean trypsin inhibitor (21.5K) and lysozyme (14-4K) were included as standards (---).
To determine the effectiveness of the 2-13F5 antibody affinity column in purifying crude interferon, material that had not been purified on a polyclonal anti-L929 cell interferon antibody column (specific activity: 1.8 x 105 units/mg of protein)was run on a 2-13F5 antibody affinity column. The material bound and eluted from the column contained 6 5~ of the total input of antiviral activity and had a specific activity of 3.2 x 108 units/mg of protein (data not shown). This data demonstrated that affinity chromatography on immobilized 2-13F5 antibody could produce-a 2000-fold increase in the purity Of interferon in one step.
S D S -P A G E was used to characterize the interferon bound to the monoclonal antibody. Because of the small amount of protein available from the column depicted in Fig. 1 (a) , a larger 2-13F5 column was loaded with seven times the quantity of interferon used on the first column and a similar elution profile was obtained. The input, wash, and eluate fractions were then Short communications * Titres are expressed as reciprocals of the dilution of supernatant (i.e. per ml). 1" The 'wash' and 'eluate' represent the fractions obtained from affinity chromatography on immobilized 2-13F5 antibody that demonstrated peak antiviral activity.
:~ The wash and eluate represent eluted gel slices that were obtained from the peak fractions of the affinity column, that contained antiviral activity and that banded at 22K for IFN-ct and 35K for IFN-fl.
analysed by SDS-PAGE. Fig. 1 (b) , panels 1 and 2 shows three protein bands revealed by Coomassie Brilliant Blue staining of the input murine L929 cell interferon (b, 1] and wash fractions (b, 2), while only one protein band with a tool. wt. of 35K was observed in the eluate from the 2-13F5 affinity column (panel 3). The corresponding profile of interferon activity showed two peaks associated with both the input and wash; one at 35K and one at 22K, IFN-fl and -~ respectively (panels 1 and 2). The proportion of the IFN-fl in the wash, however, was significantly reduced from 95 ~ to 8 ~o, as compared to the input. The material eluted from the 2-13F5 column demonstrated only one peak of activity at 35K. These experiments indicate that 2-13F5 monoclonal antibody specifically binds murine IFN-fl, rather than contaminants in the interferon preparation.
One question that needed to be resolved was whether 2-13F5 monoclonal antibody was unable to neutralize antiviral activity or if the lack of neutralization against L929 cell interferon was due to the presence of IFN-0t, as well as IFN-fl, in the interferon preparation. As shown in Table 1 , 2-13F5 antibody is unable to neutralize either the input material or the wash material from the affinity chromatography; both materials contained IFN-ct and IFN-fl. The material that bound to 2-13F5 affinity column, which was only IFN-fl, was neutralized by the antibody, indicating that the 2-13F5 monoclonal antibody could both bind and neutralize IFN-fl.
The presence of a 35K species of interferon in the wash material could be due to either an overload of the affinity column or to the existence of two antigenicaUy distinct murine interferons with a mol. wt. of approximately 35K. The latter possibility is supported by two facts. Firstly, re-chromatography of the wash material through a second 2-13F5 affinity column resulted in full recovery of both the 22K and 35K species in the wash fractions and no interferon activity in the eluate, indicating that the 35K species in the wash was not an overload from the first column. Secondly, further examination of the neutralizing activity of 2-13F5 antibody demonstrated that the 35K eluate from the 2-13F5 column isolated from an SDS-PAGE gel slice could be neutralized by 2-13F5 antibody; however, interferon with a similar mol. wt. eiuted from a gel slice of the wash material of the column could not be neutralized by 2-13F5 antibody (Table  1) . These antigenically distinct murine interferons of 35K could represent two distinct subtypes of murine IFN-fl, both similar in size but perhaps with a slight variation in amino acid sequence at or near the critical antigenic site. It may also be possible that the two subtypes differ in the degree of glycosylation or that one subtype may be non-glycosylated. However, studies of glycosidase-treated IFN-fl (Fujisawa & Kawade, 1981) have shown that the antigenicity of the species was unchanged upon enzyme treatment and that the deglycosylated species was 5 x 103 to 10 x 103 daltons smaller. Similar antigenicity studies with non-glycosylated ct species have also shown no change in antigenicity relative to the glycosylated species (Fujisawa & Kawade, 1981 ; Havell & Carter, 1981) , suggesting that antigenicity is dependent upon the primary amino acid sequence of the molecule, rather than the carbohydrate moiety. The minor 35K subtype may in fact represent a partially denatured pool of the IFN-/~ species. This alternative is unlikely since this material is biologically active and retention of biological activity, as tested in our laboratory, is usually accompanied by integrity of antigenicity. An additional possibifity is that the minor 35K subtype is a dimer of IFN-~. This alternative is not very likely, since the L929 cell IFN-~ species is 22K: a dimer would be approximately 44K. In addition, the SDS-PAGE system is run under reducing conditions: no multiple forms of the proteins should exist and, indeed, no multiple forms of the species have ever been seen in our gel system. Whether the 35K subtype is actually a modification of IFN-~ is another possibility which will only be clarified by further testing. Due to the small amount of the minor 35K component, further characterization was not accomplished in this study. At this point, the most feasible explanation is that the minor 35K subtype is a fl-type interferon with different antigenic properties as the result of alterations in the primary amino acid sequence.
Apart from the application of using monoclonal antibodies to purify crude interferon efficiently, a panel of monoclonal antibodies should provide the means to identify the various antigen types and subtypes of murine interferons and to determine whether specific interferons exhibit the enhanced activity of oarticular biological functions attributed to interferon.
